Avanos Medical, Inc. (AVNS) Income Statement Analysis

See more : Iconic Sports Acquisition Corp. (ICNC) Income Statement Analysis – Financial Results

Complete financial analysis of Avanos Medical, Inc. (AVNS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Avanos Medical, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.

You may be interested

Harfang Exploration Inc. (HRFEF) Income Statement Analysis – Financial Results
Continental Aerospace Technologies Holding Limited (0232.HK) Income Statement Analysis – Financial Results
Entra ASA (ENTRA.OL) Income Statement Analysis – Financial Results
Comerton Corp. (COCM) Income Statement Analysis – Financial Results
Foxconn Technology Co., Ltd. (2354.TW) Income Statement Analysis – Financial Results

Avanos Medical, Inc. (AVNS)

Industry: Medical - Devices

Sector: Healthcare

Website: https://avanos.com

About Avanos Medical, Inc.

Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Metric	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Revenue	673.30M	820.00M	744.60M	714.80M	697.60M	652.30M	611.60M	1.59B	1.57B	1.67B	1.68B	1.68B	1.66B
Cost of Revenue	293.60M	370.00M	380.30M	341.50M	295.40M	261.40M	274.70M	1.03B	1.04B	1.12B	1.07B	1.08B	1.07B
Gross Profit	379.70M	450.00M	364.30M	373.30M	402.20M	390.90M	336.90M	557.90M	531.60M	548.60M	612.20M	602.50M	590.80M
Gross Profit Ratio	56.39%	54.88%	48.93%	52.22%	57.65%	59.93%	55.09%	35.04%	33.77%	32.81%	36.49%	35.78%	35.59%
Research & Development	27.20M	30.60M	32.30M	34.90M	37.70M	41.80M	38.20M	41.10M	32.30M	33.60M	37.90M	33.00M	31.20M
General & Administrative	0.00	0.00	0.00	0.00	0.00	340.40M	321.70M	411.10M	398.50M	424.50M	351.40M	343.00M	351.70M
Selling & Marketing	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
SG&A	318.10M	341.90M	300.30M	332.60M	399.10M	340.40M	321.70M	411.10M	398.50M	424.50M	351.40M	343.00M	351.70M
Other Expenses	0.00	3.50M	22.80M	51.90M	21.10M	8.20M	20.10M	18.30M	4.50M	-3.80M	-2.40M	-1.50M	-2.80M
Operating Expenses	375.50M	376.00M	355.40M	419.40M	457.90M	390.40M	380.00M	470.50M	435.30M	454.30M	386.90M	374.50M	380.10M
Cost & Expenses	669.10M	746.00M	735.70M	760.90M	753.30M	651.80M	654.70M	1.50B	1.48B	1.58B	1.45B	1.46B	1.45B
Interest Income	2.90M	1.20M	200.00K	1.20M	6.70M	7.80M	2.50M	600.00K	300.00K	2.90M	2.60M	2.60M	4.10M
Interest Expense	15.00M	10.00M	3.30M	15.60M	15.00M	26.40M	31.60M	32.70M	33.10M	6.00M	100.00K	800.00K	200.00K
Depreciation & Amortization	46.10M	41.10M	38.30M	42.90M	36.90M	33.50M	40.00M	41.00M	65.40M	85.40M	69.20M	57.60M	51.10M
EBITDA	50.60M	77.80M	8.90M	-2.00M	-12.10M	65.70M	-600.00K	-65.50M	-76.50M	179.70M	297.10M	288.20M	265.90M
EBITDA Ratio	7.52%	14.99%	6.37%	-0.28%	-1.73%	6.41%	3.09%	9.62%	10.29%	10.92%	17.71%	17.11%	16.02%
Operating Income	4.20M	74.00M	8.90M	-46.10M	-55.70M	500.00K	-43.10M	87.40M	-377.70M	94.30M	225.30M	228.00M	210.70M
Operating Income Ratio	0.62%	9.02%	1.20%	-6.45%	-7.98%	0.08%	-7.05%	5.49%	-23.99%	5.64%	13.43%	13.54%	12.69%
Total Other Income/Expenses	-12.10M	-8.80M	44.80M	-14.40M	-8.30M	-18.60M	-29.10M	-32.10M	-274.80M	-3.10M	2.50M	1.80M	3.90M
Income Before Tax	-7.90M	65.20M	5.80M	-60.50M	-64.00M	-18.10M	-72.20M	55.30M	-410.50M	91.20M	227.80M	229.80M	214.60M
Income Before Tax Ratio	-1.17%	7.95%	0.78%	-8.46%	-9.17%	-2.77%	-11.81%	3.47%	-26.07%	5.45%	13.58%	13.65%	12.93%
Income Tax Expense	2.00M	14.70M	600.00K	-33.30M	-18.10M	-9.60M	-40.10M	15.50M	15.80M	64.10M	73.20M	77.20M	72.20M
Net Income	-61.80M	50.50M	6.30M	-27.20M	-45.90M	57.50M	79.30M	39.80M	-426.30M	27.10M	154.60M	152.60M	142.40M
Net Income Ratio	-9.18%	6.16%	0.85%	-3.81%	-6.58%	8.81%	12.97%	2.50%	-27.08%	1.62%	9.22%	9.06%	8.58%
EPS	-1.33	1.08	0.13	-0.57	-0.96	1.22	1.69	0.85	-9.15	0.58	3.32	3.28	3.06
EPS Diluted	-1.33	1.07	0.13	-0.57	-0.96	1.22	1.69	0.85	-9.15	0.58	3.32	3.28	3.06
Weighted Avg Shares Out	46.60M	46.90M	48.10M	47.80M	47.60M	47.20M	46.52M	46.60M	46.59M	46.54M	46.51M	46.51M	46.51M
Weighted Avg Shares Out (Dil)	46.60M	47.30M	48.60M	47.80M	47.60M	47.20M	46.80M	47.00M	46.59M	46.54M	46.51M	46.51M	46.51M

Avanos Medical, Inc. Announces Third Quarter 2023 Results

November 1, 2023prnewswire.com

Strong Free Cash Flow Generation in Excess of $25 Million ALPHARETTA, Ga. , Nov. 1, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported third quarter 2023 financial results.

Why Avanos (AVNS) Might Surprise This Earnings Season

October 31, 2023zacks.com

Avanos (AVNS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Avanos Medical (AVNS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

October 25, 2023zacks.com

Avanos Medical (AVNS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Avanos Medical, Inc. to Webcast Conference Call Discussing Third Quarter 2023 Financial Results

October 25, 2023prnewswire.com

ALPHARETTA, Ga. , Oct. 25, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 2023 on Wednesday, Nov. 1 at 9 a.m.

AirLife Completes Acquisition of Avanos Medical's Respiratory Health Business

October 2, 2023businesswire.com

GRAND RAPIDS, Mich.--(BUSINESS WIRE)--AirLife, a leading North American manufacturer and distributor of consumable medical devices for anesthesia and respiratory care formerly known as SunMed, today announced the completion of its acquisition of Avanos Medical, Inc.'s (NYSE: AVNS) (“Avanos”) respiratory health...

Avanos Medical, Inc. to Present at the CL King Annual Best Ideas Conference

September 12, 2023prnewswire.com

ALPHARETTA, Ga. , Sept. 12, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president, chief financial officer, and chief transformation officer will participate in a fireside chat at CL King's virtual 21st Annual Best...